Direkt zum Inhalt
Merck

Oral potassium iodide for the treatment of sporotrichosis.

Mycopathologia (2009-01-09)
Si-Liang Xue, Li Li
ZUSAMMENFASSUNG

Potassium Iodide is the antimycotic of choice for the treatment of cutaneous sporotrichosis, because of its efficacy, safety and low cost. We carried out a review of published studies on the benefits and adverse reactions of using SSKI (Saturated Solution Potassium Iodide) as treatment for sporotrichosis, but could not identify any well-designed clinical trails. There is an urgent need to conduct randomized double-blind placebo-controlled trials and critically assess usefulness of SSKI by using a standardize monitoring or an effective self-report system.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Kaliumiodid, ACS reagent, ≥99.0%
Sigma-Aldrich
Kaliumiodid, ReagentPlus®, 99%
Sigma-Aldrich
Kaliumiodid, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Goldätzmittel, Standard
Sigma-Aldrich
Kaliumiodid, ≥99.99% trace metals basis
Sigma-Aldrich
Kaliumiodid, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
Kaliumiodid, suitable for plant cell culture
Sigma-Aldrich
Kaliumiodid, AnhydroBeads, −10 mesh, 99.998% trace metals basis
Sigma-Aldrich
Kaliumiodid, BioXtra, ≥99.0%
Sigma-Aldrich
Kaliumiodid, tested according to Ph. Eur.
Sigma-Aldrich
Kaliumiodid, puriss., meets analytical specification of Ph. Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)